Literature DB >> 10094094

Benign prostatic hyperplasia: an overview.

A Ziada1, M Rosenblum, E D Crawford.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10094094     DOI： 10.1016/s0090-4295(98)00532-9

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  18 in total

Review 1.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

3.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 4.  Tamsulosin: an update of its role in the management of lower urinary tract symptoms.

Authors:  Katherine A Lyseng-Williamson; Blair Jarvis; Antona J Wagstaff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia.

Authors:  Thomas A A Skinner; Robert J Leslie; Stephen S Steele; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

6.  Metabolic factors associated with benign prostatic hyperplasia.

Authors:  J Kellogg Parsons; H Ballentine Carter; Alan W Partin; B Gwen Windham; E Jeffrey Metter; Luigi Ferrucci; Patricia Landis; Elizabeth A Platz
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

7.  Mirabegron for male lower urinary tract symptoms.

Authors:  Oscar Suarez; David Osborn; Melissa Kaufman; W Stuart Reynolds; Roger Dmochowski
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

8.  Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients.

Authors:  Francisco Cesar Carnevale; Alberto Azoubel Antunes; Joaquim Mauricio da Motta Leal Filho; Luciana Mendes de Oliveira Cerri; Ronaldo Hueb Baroni; Antonio Sergio Zafred Marcelino; Geraldo Campos Freire; Airton Mota Moreira; Miguel Srougi; Giovanni Guido Cerri
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

9.  Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men.

Authors:  Hyun Keun Byun; Yun Hsien Sung; Won Kim; Jae Hung Jung; Jae Mann Song; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2012-11-14

10.  International Prostatic Symptom Score-voiding/storage subscore ratio in association with total prostatic volume and maximum flow rate is diagnostic of bladder outlet-related lower urinary tract dysfunction in men with lower urinary tract symptoms.

Authors:  Yuan-Hong Jiang; Victor Chia-Hsiang Lin; Chun-Hou Liao; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.